Investors Paying Too Much for Future Growth May Be Hurting Returns: Morgan Stanley

Why It Matters

Overvalued growth expectations can erode long‑term returns, prompting investors to reassess valuation models and allocate capital toward more modest‑growth opportunities. The findings challenge the dominance of aggressive growth narratives in equity markets.

Key Takeaways

• Low PVGO stocks posted 8.7% median 5‑yr TSR vs 5% high PVGO
• PVGO makes up ~35% of S&P 500 value, rest 65% earnings
• Positive return spread occurred in 90% of years, averaging 2.6 points
• By end‑2025 PVGO level exceeded historical average, signaling optimism
• PVGO outperformed value factor by 230 bps over five‑year horizon

Pulse Analysis

The present value of growth opportunities (PVGO) isolates the portion of a company’s market price that investors attribute to future projects rather than current earnings. Morgan Stanley’s analysis of billion‑dollar U.S. firms over three decades shows that a lower PVGO share consistently translates into higher total shareholder returns. By separating the valuation into existing‑business value and future‑investment value, analysts can pinpoint when market optimism has drifted into overpricing, a pattern that has historically preceded periods of muted performance.

For portfolio managers, the study offers a quantitative lens to complement traditional value metrics such as price‑to‑book ratios. As intangible assets have risen, pure book‑value approaches have lost predictive power, while PVGO captures the market’s premium on expected innovation and expansion. The report highlights that the PVGO component now represents roughly one‑third of the S&P 500’s overall valuation, a level above its long‑run average, suggesting that many equities are priced for aggressive growth that may not materialize. This premium has already translated into a 2.3‑percentage‑point return spread favoring low‑PVGO stocks.

Looking ahead, investors can use PVGO as a screening tool to identify sectors where growth expectations are inflated, such as high‑flying tech or biotech names. Incorporating PVGO into multi‑factor models may improve risk‑adjusted returns, especially when combined with quality and profitability screens. However, analysts should remain cautious: a low PVGO does not guarantee superior performance if a company’s core earnings deteriorate. Continuous monitoring of the PVGO ratio relative to historical norms can help allocate capital more efficiently and avoid the pitfalls of chasing unsustainable growth narratives.